UNSPSC 85515735: Supplement right foot artery with synthetic substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right foot artery with synthetic substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04UV3JZ

UNSPSC 85515735 Supplement right foot artery with synthetic substitute, percutaneous approach (Commodity) shows little relevant recent activity under this code. The six most recent state and local opportunities posted under this UNSPSC code relate to occupational medical surveillance (Washington State Department of Transportation), independent medical evaluations for pension disability determinations (City of Phoenix), surgical benefit carve-out program management (City of Long Beach), emergency and specialty medical services for detained youth (Harris County Juvenile Probation Department), pharmacy benefit management (Collier County), and temporary health professional staffing across ancillary clinical categories (County of Santa Clara Health System). None of these solicitations involve vascular interventions, arterial supplementation procedures, or percutaneous endovascular work. The code's nominal scope—a specific surgical procedure requiring implantation of a synthetic vascular graft—does not align with the administrative healthcare contracting, staffing, and benefit management services actually being solicited.

State and local procurement activity under this code does not support actionable business development direction. The misalignment between the procedure-specific Commodity code and the general healthcare administration and staffing services appearing in recent solicitations suggests either a tagging error in the source data or a code that does not reflect current state and local purchasing patterns. Firms offering vascular surgical supplies, implantable devices, or interventional cardiology services should verify code classification through direct outreach to individual issuing bodies rather than relying on this category for opportunity identification.